PATENT CLAIM ANALYSIS

Application Number: 16138698
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["514", "051000"]

Abstract:
Cytidine nucleoside analogues of Formula I, wherein the variables are as described herein, in combination with uridine nucleoside analogues of Formula II, wherein the variables are as described herein, produce a synergistic effect on the inhibition of HCV polymerase.

Claim (Index 2):
The method of  claim 1  wherein:\n each R is independently O\u2014R 1  or NHC(R 2a )(R 2b )C(\u2550O)OR 3 ; \n each R\u2032 is independently O\u2014R 1  or NHC(R 2a )(R 2b )C(\u2550O)OR 3 ;\n each R 1  is independently phenyl or naphthyl, optionally substituted with one or more lower alkyl, lower alkoxy, halo, lower haloalkyl, or cyano; \n each R 2a  and R 2b  are independently H or lower alkyl; \n each R 3  is independently H, lower alkyl, lower haloalkyl, phenyl or phenyl lower alkyl; \n \n each X is independently O or S; \n each Y is independently H or F; and \n each Y\u2032 is independently F or OH; \n or a pharmacologically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15581834', '12402601', '10940615', '10131938', '13988354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7883464720858231
- 35 USC 102 Novelty (BERT): 0.555746052830246
- Combined Prediction Score: 0.7650864301602655
- Mean Citation Score: 388.826792
- Max Citation Score: 437.45496
- Similarity Product: 311.01007140143395

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test